CHA Stem Cell Institute
The CHA Stem Cell Institute researches both adult stem cell pipelines as well as embryonic stem cell pipelines in unison with the world’s leading universities and research scholars in order to be the leaders in curing various incurable diseases.
Patent
| No |
CONTENTS |
| 15 |
Improved modalities for the treatment of degenerative diseases of the retina.US 06/0018886, WO 06/080952) |
| 14 |
Improved methods of producing rpe cells and compositions of rpe cells. PCT/US2008/011669 |
| 13 |
A method of treating retinal degeneration, comprising: differentiating human embryonic stem cells ex vivo to produce RPE cells; isolating the RPE cells. US 06/0031951 |
| 12 |
Hemangio-Colony Forming Cells, WO 2007/120811A2, PCT/US2007/009106 |
| 11 |
Non-Engrafting Hemangio Cells. U.S. Patent (Serial No. not provided) |
| 10 |
Methods for Producing Enucleated Erythroid Cells Derived from Pluripotent Stem Cells. U.S. Patent Application (Serial No. not provided) |
| 9 |
Hemangio-Colony Forming Cells. U.S. Patent Application (Serial No. not provided) |
| 8 |
Methods for vitrification of human oocytes (US 10/581260) |
| 7 |
Method for culturing human embryonic stem cells (US 12/227,793, EP 7746787.6, JP2009-513061) |
| 6 |
Process for isolating vascular endotheliar cells from embryoid bodies differenciated from embryonic stem cells (PCT/KR2007/002840, US 11/913,295) |